207 related articles for article (PubMed ID: 18374923)
41. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
[TBL] [Abstract][Full Text] [Related]
43. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
[TBL] [Abstract][Full Text] [Related]
44. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
45. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
[TBL] [Abstract][Full Text] [Related]
46. In-stent neoatherosclerosis: a final common pathway of late stent failure.
Park SJ; Kang SJ; Virmani R; Nakano M; Ueda Y
J Am Coll Cardiol; 2012 Jun; 59(23):2051-7. PubMed ID: 22651862
[TBL] [Abstract][Full Text] [Related]
47. Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
Tsai AK; Li N; Hanson NQ; Tsai MY; Tang W
Atherosclerosis; 2009 Dec; 207(2):487-91. PubMed ID: 19596330
[TBL] [Abstract][Full Text] [Related]
48. Comparison of drug-eluting stent with bare metal stent for distal de novo unprotected left main coronary artery stenosis. A propensity score-matched cohort study.
Hsueh SK; Wu CJ; Fang HY; Hsieh YK; Fang CY; Chen CJ; Chen SM; Yang CH; Yip HK; Chen MC; Fu M; Cheng CI
Circ J; 2011; 75(2):290-8. PubMed ID: 21157111
[TBL] [Abstract][Full Text] [Related]
49. Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.
Lee MS; Kobashigawa J; Tobis J
JACC Cardiovasc Interv; 2008 Dec; 1(6):710-5. PubMed ID: 19463388
[TBL] [Abstract][Full Text] [Related]
50. Systemic immunosuppressive therapy with oral Sirolimus after bare metal stent implantation: the missing alternative in the prevention of coronary restenosis after percutaneous coronary interventions.
Rodriguez AE; Fernandez-Pereira C
Recent Pat Cardiovasc Drug Discov; 2008 Nov; 3(3):201-8. PubMed ID: 18991795
[TBL] [Abstract][Full Text] [Related]
51. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
52. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
[TBL] [Abstract][Full Text] [Related]
53. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
[TBL] [Abstract][Full Text] [Related]
55. Management of drug-eluting stent restenosis.
Ishikawa K; Aoyama Y; Hirayama H
J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
[TBL] [Abstract][Full Text] [Related]
56. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
57. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.
Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R;
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079
[TBL] [Abstract][Full Text] [Related]
58. Drug-eluting stents versus bare-metal stents in saphenous vein graft interventions: a systematic review and meta-analysis.
Wiisanen ME; Abdel-Latif A; Mukherjee D; Ziada KM
JACC Cardiovasc Interv; 2010 Dec; 3(12):1262-73. PubMed ID: 21232720
[TBL] [Abstract][Full Text] [Related]
59. A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study.
Ozaki Y; Lemos PA; Yamaguchi T; Suzuki T; Nakamura M; Ismail TF; Kitayama M; Nishikawa H; Kato O; Serruys PW
EuroIntervention; 2010 Aug; 6(3):400-6. PubMed ID: 20884421
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of everolimus-eluting stents for bare-metal in-stent restenosis.
Ota H; Mahmoudi M; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2015; 16(3):151-5. PubMed ID: 25977226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]